Literature DB >> 16479665

CT of the small intestine.

Patrik Rogalla1.   

Abstract

CT of the small intestine continues to be a diagnostic challenge. Three protocols have turned out to be useful. The frequently used general protocol is highly suitable for most indications that require an overview of the small intestine and in cases where no specific queries regarding the small intestine have to be answered. A dedicated protocol with opacification of the small intestine by means of a probe appears to be useful in patients with a suspected tumour or to exclude a tumour as well as in cases of inflammatory bowel disease. Filling of the bowel ensures optimal distention and, in combination with intravenous contrast medium administration, allows differentiation of tumours from inflammatory lesions. In cases of suspected intestinal ischaemia, angiographic techniques should be used. State-of-the-art techniques such as bolus tracking and acquisition of a dynamic scan for determination of individual circulation time facilitate optimal arterial opacification of the intestinal wall. The results obtained in our patients suggest that the use of multislice CT in combination with optimal opacification improves sensitivity. Further studies have to show whether the improved diagnostic options also translate into an improved clinical outcome or survival rate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16479665     DOI: 10.1007/s10406-005-0139-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  3 in total

Review 1.  Gastrointestinal tract imaging in children: current techniques.

Authors:  Melanie P Hiorns
Journal:  Pediatr Radiol       Date:  2010-07-02

Review 2.  Imaging of inflammatory bowel disease. How?

Authors:  Melanie P Hiorns
Journal:  Pediatr Radiol       Date:  2008-06

3.  Value of cine MRI for better visualization of the proximal small bowel in normal individuals.

Authors:  Michael R Torkzad; Roberto Vargas; Chikako Tanaka; Lennart Blomqvist
Journal:  Eur Radiol       Date:  2007-07-28       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.